An automated system for monitoring and regulating the pH of bicarbonate buffers

AAPS PharmSciTech

Volumn 14, Issue 2, 2013, Pages 517-522

  Garbacz, Grzegorz ^a,b   Kołodziej, Bartosz ^c   Koziolek, Mirko ^b   Weitschies, Werner ^b   Klein, Sandra ^b  

^a Physiolution GmbH   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c INSTITUTE OF LOW TEMPERATURE AND STRUCTURE RESEARCH   (Poland)

Author keywords

bicarbonate media; biorelevant dissolution; hydrogen carbonate buffer; modified release; physiological buffers

Indexed keywords

BICARBONATE; BUFFER; CARBON DIOXIDE; ELECTROLYTE; SODIUM ION;

ACCURACY; ARTICLE; AUTOMATION; COMPUTER PROGRAM; DISSOLUTION; GAS EXCHANGE; GASTRIC PH MONITORING; HUMAN; MICROPROCESSOR; PH ELECTRODE; PH MEASUREMENT; PRIORITY JOURNAL; THERMOSTABILITY;

AUTOMATION, LABORATORY; BICARBONATES; BUFFERS; CARBON DIOXIDE; EQUIPMENT DESIGN; GASES; HYDROGEN-ION CONCENTRATION; MICROCOMPUTERS; MICROELECTRODES; MODELS, CHEMICAL; SOFTWARE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 84879069115     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-9933-5     Document Type: Article

References (21)

1. Diakidou A et al. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res. 2009;26(9):2141-51.
2. Vertzoni M et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J Pharm Pharmacol. 2004;56(4):453-62.
3. Kalantzi L et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res. 2006;23(1):165-76.
4. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364(2):213-26.
5. Persson EM et al. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res. 2005;22(12):2141-51.
6. Repishti M et al. Human duodenal mucosal brush border Na(+)/H(+) exchangers NHE2 and NHE3 alter net bicarbonate movement. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G159-63.
7. Liu F et al. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Eur J Pharm Biopharm. 2011;78(1):151-7.
8. Fadda HM et al. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. Int J Pharm. 2009;382(1-2):56-60.
9. Bodmeier R et al. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D. Pharm Res. 1996;13(1):52-6.
10. Wagner K, McGinity J. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films. J Control Release. 2002;82(2-3):385-97.
11. Wagner KG, Gruetzmann R. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings. AAPS J. 2005;7(3):E668-77.
12. Ibekwe VC et al. An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J Pharm Sci. 2006;95(12):2760-6.
13. Ibekwe VC et al. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. Pharm Res. 2008;25(8):1828-35.
14. McNamara DP, Whitney KM, Goss SL. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. Pharm Res. 2003;20(10):1641-6.
15. Sheng JJ, McNamara DP, Amidon GL. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol Pharm. 2009;6(1):29-39.
16. Mooney KG et al. Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions. J Pharm Sci. 1981;70(1):13-22.
17. Mooney KG et al. Dissolution kinetics of carboxylic acids II: effect of buffers. J Pharm Sci. 1981;70(1):22-32.
18. Bai G et al. Hydrodynamic investigation of USP dissolution test apparatus II. J Pharm Sci. 2007;96(9):2327-49.
19. Bai G, Wang Y, Armenante PM. Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at different impeller agitation speeds. Int J Pharm. 2011;403(1-2):1-14.
20. Bai G, Armenante PM. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. J Pharm Sci. 2009;98(4):1511-31.
21. Kukura J, Baxter JL, Muzzio FJ. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. Int J Pharm. 2004;279(1-2):9-17.